Atlas Trials

Effect of Fingolimod on Neurodegeneration

Clinical trial NCT02575365 · TERMINATED

Trial details

NCT number
NCT02575365
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
CognitionBrain Volume Loss
Start date
2016-02-16
Primary completion
2017-01-27
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.